{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T14:16:54Z","timestamp":1789913814467,"version":"4.0.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Eye Institute Core","award":["P30EY013080"],"award-info":[{"award-number":["P30EY013080"]}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.xphs.2016.09.019","type":"journal-article","created":{"date-parts":[[2016,10,24]],"date-time":"2016-10-24T22:30:51Z","timestamp":1477348251000},"page":"3691-3701","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Stability and Ocular Pharmacokinetics of Celecoxib-Loaded Nanoparticles Topical Ophthalmic Formulations"],"prefix":"10.1016","volume":"105","author":[{"given":"Mohammed Mostafa","family":"Ibrahim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abd-Elgawad Helmy","family":"Abd-Elgawad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osama Abd-Elazeem","family":"Soliman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica M.","family":"Jablonski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xphs.2016.09.019_bib1","series-title":"Bioavailability","article-title":"Duane's ophthalmology","author":"Ananthula","year":"2009"},{"issue":"2","key":"10.1016\/j.xphs.2016.09.019_bib2","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.actbio.2009.07.021","article-title":"Cyclodextrin-containing hydrogels for contact lenses as a platform for drug incorporation and release","volume":"6","author":"Xu","year":"2010","journal-title":"Acta Biomater"},{"key":"10.1016\/j.xphs.2016.09.019_bib3","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1248\/bpb.30.1768","article-title":"Ability of poly-L-arginine to enhance drug absorption into aqueous humor and vitreous body after instillation in rabbits","volume":"30","author":"Nemoto","year":"2007","journal-title":"Biol Pharm Bull"},{"issue":"34","key":"10.1016\/j.xphs.2016.09.019_bib4","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1039\/b605640g","article-title":"Polymeric materials for ophthalmic drug delivery: trends and perspectives","volume":"16","author":"Barbu","year":"2006","journal-title":"J\u00a0Mater Chem"},{"issue":"8","key":"10.1016\/j.xphs.2016.09.019_bib5","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S1461-5347(98)00087-X","article-title":"Recent developments in ophthalmic drug delivery","volume":"1","author":"Ding","year":"1998","journal-title":"Pharm Sci Technol Today"},{"issue":"2","key":"10.1016\/j.xphs.2016.09.019_bib6","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.survophthal.2009.07.005","article-title":"Nonsteroidal anti-inflammatory drugs in ophthalmology","volume":"55","author":"Kim","year":"2010","journal-title":"Surv Ophthalmol"},{"issue":"4","key":"10.1016\/j.xphs.2016.09.019_bib7","doi-asserted-by":"crossref","first-page":"R735","DOI":"10.1152\/ajpregu.00080.2003","article-title":"Interaction between NO and COX pathways in retinal cells exposed to elevated glucose and retina of diabetic rats","volume":"287","author":"Du","year":"2004","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"2","key":"10.1016\/j.xphs.2016.09.019_bib8","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/IAE.0b013e3181884fa6","article-title":"Expression of cyclooxygenase-2 in choroidal neovascular membranes from age-related macular degeneration patients","volume":"29","author":"Maloney","year":"2009","journal-title":"Retina"},{"issue":"6","key":"10.1016\/j.xphs.2016.09.019_bib9","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.ajo.2005.01.030","article-title":"Celecoxib, a selective inhibitor of cyclooxygenase 2 for therapy of diffuse anterior scleritis","volume":"139","author":"Bauer","year":"2005","journal-title":"Am J Ophthalmol"},{"issue":"10","key":"10.1016\/j.xphs.2016.09.019_bib10","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1023\/B:PHAM.0000045231.51924.e8","article-title":"Retinal delivery of celecoxib is several-fold higher following subconjunctival administration compared to systemic administration","volume":"21","author":"Ayalasomayajula","year":"2004","journal-title":"Pharm Res"},{"issue":"3","key":"10.1016\/j.xphs.2016.09.019_bib11","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1167\/iovs.05-0531","article-title":"Single periocular injection of celecoxib-PLGA microparticles inhibits diabetes-induced elevations in retinal PGE2, VEGF, and vascular leakage","volume":"47","author":"Amrite","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2-3","key":"10.1016\/j.xphs.2016.09.019_bib12","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ejphar.2005.02.019","article-title":"Subconjunctivally administered celecoxib-PLGA microparticles sustain retinal drug levels and alleviate diabetes-induced oxidative stress in a rat model","volume":"511","author":"Ayalasomayajula","year":"2005","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.xphs.2016.09.019_bib13","series-title":"Pharmaceutical dosage forms, ophthalmic preparation and uniformity of dosage units chapters","article-title":"\u201cThe United States Pharmacopeia\u201d 29th, the National Formulary 24th","year":"2005"},{"issue":"3","key":"10.1016\/j.xphs.2016.09.019_bib14","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1002\/jps.23417","article-title":"Nanoparticle-based topical ophthalmic formulations for sustained celecoxib release","volume":"102","author":"Ibrahim","year":"2013","journal-title":"J\u00a0Pharm Sci"},{"issue":"1","key":"10.1016\/j.xphs.2016.09.019_bib15","doi-asserted-by":"crossref","first-page":"7","DOI":"10.7243\/2050-120X-2-7","article-title":"Natural bioadhesive biodegradable nanoparticles-based topical ophthalmic formulations for sustained celecoxib release: in\u00a0vitro study","volume":"2","author":"Ibrahim","year":"2013","journal-title":"J\u00a0Pharm Tech Drug Res"},{"issue":"11","key":"10.1016\/j.xphs.2016.09.019_bib16","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1007\/s11095-013-1109-1","article-title":"Novel topical ophthalmic formulations for management of glaucoma","volume":"30","author":"Ibrahim","year":"2013","journal-title":"Pharm Res"},{"issue":"3","key":"10.1016\/j.xphs.2016.09.019_bib17","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1167\/tvst.4.3.12","article-title":"Natural bioadhesive biodegradable nanoparticle-based topical ophthalmic formulations for management of glaucoma","volume":"4","author":"Ibrahim","year":"2015","journal-title":"Transl Vis Sci Technol"},{"issue":"5","key":"10.1016\/j.xphs.2016.09.019_bib18","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0731-7085(01)00523-4","article-title":"Stability-indicating methods for the determination of doxazosin mezylate and celecoxib","volume":"27","author":"Bebawy","year":"2002","journal-title":"J\u00a0Pharm Biomed Anal"},{"issue":"2-3","key":"10.1016\/j.xphs.2016.09.019_bib19","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0168-3659(99)00223-0","article-title":"Vitamin A-loaded solid lipid nanoparticles for topical use: drug release properties","volume":"66","author":"Jenning","year":"2000","journal-title":"J\u00a0Control Release"},{"issue":"1","key":"10.1016\/j.xphs.2016.09.019_bib20","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1167\/iovs.07-0214","article-title":"Effect of eye pigmentation on transscleral drug delivery","volume":"49","author":"Cheruvu","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xphs.2016.09.019_bib21","series-title":"Basic Statistics for the Health Sciences","author":"Kuzma","year":"2005"},{"issue":"2","key":"10.1016\/j.xphs.2016.09.019_bib22","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jconrel.2007.07.009","article-title":"In situ-forming hydrogels for sustained ophthalmic drug delivery","volume":"122","author":"Nanjawade","year":"2007","journal-title":"J\u00a0Control Release"},{"key":"10.1016\/j.xphs.2016.09.019_bib23","series-title":"Stability of Medicinal Products. The Pharmaceutical Codex","first-page":"277","author":"Lund","year":"1994"},{"issue":"1","key":"10.1016\/j.xphs.2016.09.019_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.colsurfb.2009.09.001","article-title":"Biodegradable polymeric nanoparticles based drug delivery systems","volume":"75","author":"Kumari","year":"2010","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"1-2","key":"10.1016\/j.xphs.2016.09.019_bib25","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ijpharm.2007.04.013","article-title":"Gels and liposomes in optimized ocular drug delivery: studies on ciprofloxacin formulations","volume":"343","author":"Budai","year":"2007","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1016\/j.xphs.2016.09.019_bib26","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ijpharm.2008.08.013","article-title":"Investigation of the carbopol gel of solid lipid nanoparticles for the transdermal iontophoretic delivery of triamcinolone acetonide acetate","volume":"364","author":"Liu","year":"2008","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1016\/j.xphs.2016.09.019_bib27","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0168-3659(02)00175-X","article-title":"Thermosetting gels with modulated gelation temperature for ophthalmic use: the rheological and gamma scintigraphic studies","volume":"83","author":"Wei","year":"2002","journal-title":"J\u00a0Control Release"},{"issue":"1","key":"10.1016\/j.xphs.2016.09.019_bib28","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0169-409X(97)00048-3","article-title":"Biodegradation and biocompatibility of PLA and PLGA microspheres","volume":"28","author":"Shive","year":"1997","journal-title":"Adv Drug Deliv Rev"},{"issue":"1-2","key":"10.1016\/j.xphs.2016.09.019_bib29","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0378-5173(02)00483-0","article-title":"Biodegradable poly(epsilon-caprolactone) nanoparticles for tumor-targeted delivery of tamoxifen","volume":"249","author":"Chawla","year":"2002","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1016\/j.xphs.2016.09.019_bib30","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ejps.2012.05.010","article-title":"Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?","volume":"47","author":"Das","year":"2012","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"10.1016\/j.xphs.2016.09.019_bib31","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0378-5173(96)04441-9","article-title":"Intranasal mucociliary clearance of putative bioadhesive polymer gels","volume":"135","author":"Zhou","year":"1996","journal-title":"Int J Pharm"},{"issue":"1-2","key":"10.1016\/j.xphs.2016.09.019_bib32","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0378-5173(01)00760-8","article-title":"Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A","volume":"224","author":"De Campos","year":"2001","journal-title":"Int J Pharm"},{"issue":"11","key":"10.1016\/j.xphs.2016.09.019_bib33","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1211\/0022357022476","article-title":"The potential of chitosan in ocular drug delivery","volume":"55","author":"Alonso","year":"2003","journal-title":"J\u00a0Pharm Pharmacol"},{"issue":"1","key":"10.1016\/j.xphs.2016.09.019_bib34","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.addr.2009.11.026","article-title":"Chitosan-based nanostructures: a delivery platform for ocular therapeutics","volume":"62","author":"De la Fuente","year":"2010","journal-title":"Adv Drug Deliv Rev"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354916417442?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354916417442?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,7]],"date-time":"2018-09-07T08:51:39Z","timestamp":1536310299000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354916417442"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":34,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S0022354916417442"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2016.09.019","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stability and Ocular Pharmacokinetics of Celecoxib-Loaded Nanoparticles Topical Ophthalmic Formulations","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2016.09.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}